Hemostasis Products Market Size, Share & Growth (2022-27)

 Market Overview:

The Hemostasis products market is expected to witness a CAGR of 5.2% during the forecast period (2022–2027).

The COVID-19 pandemic had a sizable effect on the market for hemostasis products. Patients treated in hospitals for COVID-19 tend to have an inflammatory response and, as a result, hypercoagulability, which is a broad term for the risk of developing pathological blood clots, also known as thrombosis or venous thromboembolism. This is stated in the study titled “Pandemic care: The need for hemostasis testing in critically ill COVID-19 patients” published in the Journal of haematology in May 2020. (VTE). Hemostasis may also be regarded as a risk factor for COVID-19 disease severity and mortality, according to a November 2021 article titled “Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.”

Scope of the Report:

As per the scope of the report, hemostasis is a process that prevents and stops bleeding, meaning keeping blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. This involves coagulation, blood changing from a liquid to a gel. Hemostasis products are those which improve the hemostasis procedure outcomes and enhance overall patient care.

Read Full Report


Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)